Lv4
485 积分 2021-06-29 加入
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
4小时前
待确认
Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer
3天前
已完结
TP53突变对非小细胞肺癌表皮生长因子受体突变患者酪氨酸激酶抑制剂的治疗效果和预后影响
27天前
已完结
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
1个月前
已完结
Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer
1个月前
已完结
Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing
1个月前
已完结
p53/ TP53 Status Assessment in Gastroesophageal Adenocarcinoma
1个月前
已完结
p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies
1个月前
已完结
The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
1个月前
已完结
皖公网安备34019202002308
